Eversheds Sutherland Sweden advised Neola Medical on its SEK 20 million directed share issue, welcoming the company’s first institutional investors
April 15, 2025
Eversheds Sutherland Sweden advised Neola Medical on its SEK 20 million directed share issue, welcoming the company’s first institutional investorsApril 15, 2025 Neola Medical AB (publ) revolutionizes neonatal intensive care with Neola®—a medical device enabling continuous lung monitoring and real-time alerts for life-threatening complications using advanced technology to measure lung volume changes and oxygen concentration. The proceeds from the share issue will support ongoing clinical studies on preterm babies and preparations for the planned FDA application for Neola® in the U.S. Eversheds Sutherland’s team consisted of Johan Engström, Kevin Holmkvist and Hanna Ullerholt. Handelsbanken acted as Sole Manager and Bookrunner in connection with the directed share issue. Key contacts
Latest Events
virtual Employment law in the Kingdom of Saudi Arabia September 29, 2026 9.30am - 12.30pm (BST) Virtual in-person Labor relations conference - turning legal change into workplace reality October 08, 2026 10.00am - 4.00pm (BST) London, United Kingdom virtual Energy Transition Series: Energy Transition and Pricing Volatility October 08, 2026 10:00 ET | 15:00 BST | 16:00 CET virtual October 14, 2026 2pm - 5pm (GMT) Virtual |